Magnus Ingelman‐Sundberg

Researcher Next ID · RN-003589

Researcher · Pharmacology, Toxicology and Pharmaceutics

Stockholm, Sweden

Not currently recruitingFunding unknown

Research interests

Pharmacology, Toxicology and Pharmaceutics

Medicine

Biochemistry, Genetics and Molecular Biology

Pharmacogenetics and Drug Metabolism

Drug Transport and Resistance Mechanisms

Eicosanoids and Hypertension Pharmacology

Alcohol Consumption and Health Effects

Drug-Induced Hepatotoxicity and Protection

Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
Pharmacology & Therapeutics · 2007 · https://doi.org/10.1016/j.pharmthera.2007.09.004
A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants
Clinical Pharmacology & Therapeutics · 2006 · https://doi.org/10.1016/j.clpt.2005.10.002
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
The Pharmacogenomics Journal · 2004 · https://doi.org/10.1038/sj.tpj.6500285
Dietary long-chain n−3 fatty acids for the prevention of cancer: a review of potential mechanisms
American Journal of Clinical Nutrition · 2004 · https://doi.org/10.1093/ajcn/79.6.935
Metabolic gene polymorphism frequencies in control populations.
PubMed · 2001

No projects listed.